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Aminoglycoside antibiotics are widely used for the treatment of life-threatening bacterial
infections, but cause permanent hearing loss in a substantial proportion of treated
patients. The sensory hair cells of the inner ear are damaged following entry of these
antibiotics via the mechano-electrical transducer (MET) channels located at the tips of
the hair cell’s stereocilia. d-Tubocurarine (dTC) is a MET channel blocker that reduces the
loading of gentamicin-Texas Red (GTTR) into rat cochlear hair cells and protects them
from gentamicin treatment. Berbamine is a structurally related alkaloid that reduces GTTR
labeling of zebrafish lateral-line hair cells and protects them from aminoglycoside-induced
cell death. Both compounds are thought to reduce aminoglycoside entry into hair cells
through theMET channels. Here we show that dTC (≥6.25µM) or berbamine (≥1.55µM)
protect zebrafish hair cells in vivo from neomycin (6.25 µM, 1 h). Protection of zebrafish
hair cells against gentamicin (10 µM, 6 h) was provided by ≥25 µM dTC or ≥12.5
µM berbamine. Hair cells in mouse cochlear cultures are protected from longer-term
exposure to gentamicin (5 µM, 48 h) by 20 µM berbamine or 25 µM dTC. Berbamine
is, however, highly toxic to mouse cochlear hair cells at higher concentrations (≥30 µM)
whilst dTC is not. The absence of toxicity in the zebrafish assays prompts caution in
extrapolating results from zebrafish neuromasts to mammalian cochlear hair cells. MET
current recordings from mouse outer hair cells (OHCs) show that both compounds are
permeant open-channel blockers, rapidly and reversibly blocking the MET channel with
half-blocking concentrations of 2.2 µM (dTC) and 2.8 µM (berbamine) in the presence of
1.3 mMCa2+ at−104 mV. Berbamine, but not dTC, also blocks the hair cell’s basolateral
K+ current, IK,neo, and modeling studies indicate that berbamine permeates the MET
channel more readily than dTC. These studies reveal key properties of MET-channel
blockers required for the future design of successful otoprotectants.
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INTRODUCTION
Aminoglycoside antibiotics are prescribed worldwide as an
effective treatment for serious and life-threatening conditions
including tuberculosis, sepsis, neonatal infections, and those
associated with cystic fibrosis (Rizzi and Hirose, 2007; Durante-
Mangoni et al., 2009). The potency of these drugs against such
infections ensures their continued use despite the knowledge
that they are both nephro- and ototoxic (Forge and Schacht,
2000). Whilst kidney damage is reversible, a degree of permanent
hearing loss is found in around 20–30% of patients treated with
these antibiotics (Rizzi and Hirose, 2007; Schacht et al., 2012).
The hearing loss is the result of damage caused to the sensory hair
cells in the inner ear, an organ in which the aminoglycosides are
found to selectively accumulate, with the basal, high-frequency
outer hair cells (OHCs) being those that are predominantly
affected (Forge and Schacht, 2000; Nakashima et al., 2000).
The main route of aminoglycoside entry into the hair cells
is via their mechano-electrical transducer (MET) channels, large
non-selective cation channels located at the tips of the hair
cells’ stereocilia (Marcotti et al., 2005; Alharazneh et al., 2011;
Vu et al., 2013). Evidence for the molecular identity of the
MET channel is increasingly suggesting that the transmembrane
channel-like (TMC) family proteins, TMC1, and TMC2, are
prime candidates (Kawashima et al., 2011, 2015; Pan et al., 2013;
Kurima et al., 2015; Corey andHolt, 2016; Fettiplace, 2016). Once
inside the cells the aminoglycosides disrupt various pathways
and organelles, resulting in the activation of multiple signaling
cascades including those involving the caspases (Forge and Li,
2000; Matsui et al., 2002, 2004; Owens et al., 2007). In the absence
of alternative antibiotics of similar efficacy, identifying methods
to protect the hair cells from this damage is crucial. Although one
approach is to interrupt the intracellular pathways this may prove
complex as, for example, the two closely-related aminoglycosides
neomycin and gentamicin have been found to activate distinct
cell-death pathways in zebrafish lateral line hair cells (Owens
et al., 2009; Coffin et al., 2013a,b). Arguably, a more effective
and universal method would be to administer compounds that
block the MET channels and prevent aminoglycoside entry into
the cells.
d-Tubocurarine (dTC), historically known as the main active
component of the arrow poison, curare, is a naturally occurring
alkaloid obtained from the bark of the South American plant
Chondrodendron tomentosum (Perotti, 1977). It is a nicotinic
antagonist that has been shown to block the acetylcholine
receptor response in mature guinea-pig OHCs (Housley and
Ashmore, 1991; Eróstegui et al., 1994) as well as the MET
channels in neonatal mouse cochlear OHCs (Glowatzki et al.,
1997). A study into the pore of the MET channels in turtle
auditory hair cells reported that curare acts as a non-permeant
blocker of these channels (Farris et al., 2004), making this an
interesting molecule to investigate for potential otoprotective
properties. The co-application of 1 mM curare was shown to
significantly reduce the loading of 3 µM Texas Red conjugated
gentamicin (GTTR) into rat cochlear inner hair cells (IHCs) and
OHCs (Alharazneh et al., 2011) suggesting a competitive block of
the pore, and the presence of 1 mM curare during the exposure
of rat cochlear cultures to 0.1 mM gentamicin prevented hair-cell
death from occurring during a subsequent 48-h antibiotic-free
period (Alharazneh et al., 2011).
Looking for other potential MET channel blockers, we
identified berbamine as having a very similar chemical structure
to dTC. Berbamine is a naturally occurring alkaloid that is
present in a number of plant species within the Berberidaceae
family (Rahmatullah et al., 2014). It has been used in Eastern
medicine for centuries to treat inflammation and related
conditions such as rheumatoid arthritis and is still of interest
to date for its potential anti-cancer properties (Ji et al., 2009;
Meng et al., 2013; Rahmatullah et al., 2014; Zhao et al., 2016).
Studies on zebrafish lateral line hair cells have revealed that
25 µM berbamine can protect these cells from the damage
caused by 50–400 µM of either neomycin or gentamicin (Kruger
et al., 2016). Furthermore, these authors found that berbamine
blocked the loading of both GTTR and FM1-43, a styryl dye
that acts as a permeant blocker of the hair cells’ MET channels
(Gale et al., 2001), leading Kruger et al. (2016) to conclude that
berbamine is providing protection by competitively blocking the
MET channels.
The zebrafish lateral line system is a useful and effective
model for initial screening, with the hair cells being both
structurally and functionally similar to mammalian inner ear
hair cells and externally located, making them easily accessible
for pharmacological studies. A degree of caution is however
required as to date only three of the compounds that have
been identified to protect lateral line hair cells have also been
shown to protect mammalian inner ear hair cells (PROTO1,
tacrine, and phenoxybenzamine; Owens et al., 2008; Ou et al.,
2009; Majumder et al., 2017). We therefore sought to ascertain
if berbamine would protect mammalian hair cells from the
toxic side effects of aminoglycoside antibiotics and, likewise, if
dTC would protect zebrafish lateral line hair cells. Furthermore,
we fully characterized how dTC blocks the MET channel in
mammalian OHCs and whether berbamine, like dTC, acts in
a similar fashion or otherwise. Comparisons between the two
structurally related molecules will assist in understanding the
features/characteristics of a compound that are required to
provide optimum otoprotection.
MATERIALS AND METHODS
Zebrafish Husbandry and Embryo
Generation
Zebrafish embryos were obtained from sibling crosses of adult AB
fish. Embryos were staged following standard protocols (Kimmel
et al., 1995;Westerfield, 2000) and raised at 28.5◦C in E3medium
(1 mMNaCl, 0.17 mM KCl, 0.33 mMMgSO4, 0.33 mM CaCl2).
Zebrafish Protection Assay
AB larvae (4 days post fertilization, dpf) were pre-incubated
with 3 µM of Yo-Pro-1 (Molecular Probes Y3603) for 30min
to label the hair cells, washed and pipetted into 96-well plates
(three larvae per well). Larvae were co-incubated with serial
dilutions of test compound (dTC or berbamine) ranging from
200 to 1.55 µM with 6.25 µM neomycin sulfate (Sigma N1876)
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for 1 h, or with 10 µM gentamicin sulfate (Sigma G3632) for
6 h. Plates were screened on a Zeiss IM35 inverted microscope
with a 16X objective. Trunk neuromasts 3–9 were viewed for
qualitative assessment of damage. Images of trunk neuromast 4 of
all three larvae in each well were taken on a Nikon D5000 at 40X
magnification and individual cells within the neuromast counted
for quantitative analysis. Experiments were repeated at least four
times.
Mouse Cochlear Culture Preparation
Cochlear cultures were prepared from wild-type CD-1 mice as
previously described by Russell and Richardson (1987). In brief,
postnatal day 2 (P2) pups of either sex were killed by cervical
dislocation following Home Office guidelines. Decapitated
heads were surface sterilized by three 1-min washes in 80%
ethanol. Sagittal incisions were made down the midline of the
head and cochleae were removed. Subsequent dissections were
performed in Hanks’ Balanced Salt Solution (HBSS; Thermo
Shandon 14025050) buffered with 10 mM Hepes (Sigma H0887)
(HBHBSS). Cochleae were removed from the bony labyrinth
and explanted onto collagen-coated (Corning 354236) coverslips
in cochlear culture medium (93% DMEM-F12, 7% fetal bovine
serum and 10 µg.ml−1 ampicillin). The coverslips complete with
cochleae were then sealed in Maximow slide assemblies and the
cultures were left to grow and adhere to the collagen in a 37◦C
incubator before use.
Mouse Cochlear Culture Protection Assay
Following 24 h incubation coverslips with adherent cochleae
were removed from the Maximow slide assemblies, placed in 35
mm petri dishes (Greiner Bio-One 627161) and incubated for
48 h in the presence of 1ml of cochlear culture medium that had
been diluted with DMEM-F12 to reduce the serum concentration
to 1.4%, together with 5 µM gentamicin (Sigma G3632) and
varying concentrations of berbamine or dTC. Following 48-h
incubation, cultures were washed in phosphate buffered saline
(PBS), fixed in 3.7% formaldehyde (Sigma F1635) in 0.1 M
sodium phosphate buffer pH 7.4, and stained with TRITC-
phalloidin (Sigma P1951). Cultures were mounted on glass slides
with Vectashield (Vector Laboratories H-1000) and imaged using
a Zeiss Axioplan2 microscope. Images were obtained from the
middle of the basal coil at a position ∼20% along the length
of the cochlea, measured from the basal tip. For quantification,
the OHCs in these images were counted and averaged across
a number of experiments. Image width was 220 µm and was
aligned along the length of the cochlea.
Mouse Cochlear Culture Electrophysiology
Recordings were made from OHCs in organotypic cultures that
had been maintained for 1–3 days in vitro. The organotypic
cultures were transferred to the microscope chamber on their
collagen-coated coverslips and the chamber was continuously
perfused with an extracellular solution containing (in mM): 135
NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-
glucose, 10 HEPES-NaOH, 2 sodium pyruvate. MEM amino
acids solution (50X) and MEM vitamins solution (100X) were
added to a final concentration of 1X from concentrates (Fisher
Scientific). The pH was adjusted to 7.48 with 1 molar NaOH
(osmolality ∼308 mOsmol kg−1). The organs of Corti were
observed with an upright microscope (Olympus) with Nomarski
differential interference contrast optics (40X water-immersion
objective). Whole-cell patch-clamp recordings were obtained
from basal-coil OHCs at room temperature (20–23◦C) using an
Optopatch (Cairn Research) patch-clamp amplifier. For MET
current recordings patch pipettes (2.5–3.0 M) contained the
following (in mM): 137 CsCl, 2.5 MgCl2, 1 EGTA-CsOH,
2.5 Na2ATP, 10 sodium phosphocreatine, 5 HEPES-CsOH; pH
adjusted to 7.3 with CsOH (osmolality ∼295 mOsmol kg−1).
For recording basolateral potassium currents patch pipettes
contained (in mM): 131 KCl, 3 MgCl2, 5 Na2ATP, 1 EGTA-
KOH, 5 HEPES, 10 sodium phosphocreatine, pH adjusted to
7.28 with KOH (osmolality ∼295 mOsmol kg−1). Patch pipettes
were coated with surf wax (Mr. Zogs SexWax) to minimize the
fast capacitance transient across the wall of the patch pipette.
MET currents were elicited by stimulating the OHC hair bundles
using a fluid jet from a pipette (tip diameter 8–10 µm) driven
by a piezoelectric disc (Kros et al., 1992; Marcotti et al., 2005).
Mechanical stimuli (filtered at 1.0 kHz, 8-pole Bessel) were
applied as 45 Hz sinusoids or, to quantify kinetics of block,
voltage steps, with driver voltage amplitudes of ±40 V, sufficient
to elicit large, saturating MET currents. Currents were acquired
using pClamp (Molecular Devices) software and stored on a
computer for off-line analysis. To look at extracellular block
the compounds were locally superfused onto the OHCs at
concentrations ranging from 300 nM to 100 µM in a solution
containing (in mM): 145 NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2,
0.7 NaH2PO4, 5.6 glucose, 10 HEPES-NaOH, 2 sodium pyruvate.
The pH was adjusted to 7.48 with NaOH (osmolality ∼305
mOsmol kg−1). This solution, without any compound, was
superfused as a control solution before and after the application
of each compound. A modest negative pressure applied to the
tip of the fluid jet pipette resulted in the compound-containing
solution being sucked into the pipette during superfusion. This
prevented mixing and dilution of the compound with bath
solution during fluid jet stimulation. To look at intracellular
block the compounds were included in the patch-pipette solution
at concentrations ranging from 100 µM to 1 mM. MET currents
obtained at the beginning of each recording were used as
controls, by which time the compounds would not yet have
diffused into the cells.
MET current size was determined by measuring the difference
between the minimum current during the inhibitory phase of the
sinewave and the current ∼6 ms after the onset of the excitatory
phase of the sinewave, a time point at which the current would
have reached near steady state. The current sizes were averaged
for each 22 ms phase of the sinewave, omitting the first cycle.
Basolateral currents were determined by measuring the steady-
state current toward the end of the voltage-step. Series resistance
compensation was applied (50–80%) and the average residual
series resistance was calculated to be 1.73 ± 0.10 M (n = 78).
The average maximum MET current size was 1.54 ± 0.08 nA
(n = 66), and the average maximum basolateral current was
2.09 ± 0.11 nA (n = 12). This would result in a maximum
voltage drop across the residual series resistance of 2.7 and 3.6
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mV respectively, considered sufficiently small to not require any
correction to quoted voltage values. All voltages reported include
a −4 mV correction for the liquid junction potential between
extra- and intra-cellular solutions.
Two-Barrier One Binding-Site Model of
Permeant Block of the MET Channel
The model used is a modification of that used for describing
permeation and block by dihydrostreptomycin (DHS; Marcotti
et al., 2005), to allow for values of the Hill coefficient (a measure
of the degree of cooperativity of the binding process of blocker
molecules to the binding site) that are greater or less than unity
(van Netten and Kros, 2007). Assuming that the fraction of
unblocked transducer channels is indicated by C, the fraction of
blocked channels by CB, the extra- and intracellular blocker by
Bo and Bi, the Hill coefficient by nH, and using the forward (k1,
k2) and reverse (k−1, k−2) rate constants, the reaction equation is
given by:
C + nHB0
k1
⇔
k−1
CBnH
k2
⇔
k−2
C + nHBi. (1)
Introducing the time variable t, the dynamics of the two fractions
are denoted by C(t) and CB(t) = 1− C(t). The rate of change
of C(t) is dependent on the four rate constants k1, k−1, k2,
k−2 of the transitions across the barriers and the intra- and
extracellular blocker concentrations, [Bi] and [Bo]. We assume
that the intracellular compound concentration Bi is small and it
is therefore set to zero ([Bi = 0]).
The voltage across the MET channel is assumed to vary with
a fixed gradient so that it linearly changes the free energy across
the membrane, effectively tilting the overall free energy profile
in proportion to the membrane potential V. The maxima of the
free energy related to the barriers are defined as E1 and E2 and
the minimum free energy related to the binding site as Eb, with
respect to V = 0. We further assume that the two barriers are
located at both sides of the membrane so that their fractional
positions across the membrane are δ1 = 0 (outside), and δ2 = 1
(inside). This is a simplification of, but otherwise similar to, that
used in a previous study of block by DHS, where the barriers were
positioned just inside the field (Marcotti et al., 2005).
Block of GTTR Loading in Mouse Cochlear
Cultures
Cochlear cultures on the collagen-coated coverslips were
transferred from the Maximow slide assemblies into a viewing
chamber in which they were incubated for 5 min in HBHBSS
together with 1% DMSO and 100 µM of compound (dTC or
berbamine) or 1% DMSO vehicle alone. GTTR was then added
to a final concentration of 0.2 µM and left for 10 min. The
cultures were washed three times and imaged using a 60X dipping
lens on a Zeiss Axioplan2 microscope. Fluorescence intensity
values were obtained from ten cells for each condition from
images captured at a time point 27 min from the start of the
experiment. Experiments for each condition were repeated three
times (30 cells total) and the intensity values averaged. Images
were obtained from a region that was ∼800 µm from the basal
tip of the cochlea.
Compound Analysis
Structures of dTC and berbamine were prepared, energy
minimized (using MMFF94x forcefield) and flexibly aligned
using Molecular Operating Environment (MOE) 2015.10.
pKa was calculated using MarvinSketch 16.8.15.0, ChemAxon
(https://www.chemaxon.com).
Statistical Analysis
Values of half-blocking concentration (KD) and Hill coefficient
(nH) determined from fitting dose-response curves were tested
for significant differences using 95% confidence intervals (CI).
This is equivalent to p < 0.05 being the criterion for
statistical significance. Multiple comparisons were made using
1-way ANOVA with Dunnett (cell counts) or Tukey (GTTR
fluorescence) post tests. Compounds were considered fully
protective if the cell counts differed significantly from the cell
counts in the presence of aminoglycoside antibiotic (neomycin
or gentamicin) alone, but not from the cell counts in the control
medium. Compounds were considered partially protective if
cell counts differed significantly from both aminoglycoside and
control media. Means are quoted and shown in Figures ± SEM.
Level of statistical significance is shown in Figures as follows:
∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.001.
Study Approval
Animals were raised following Home Office guidelines. All
experiments were performed in accordance with the HomeOffice
Animals (Scientific Procedures) Act 1986 and approved by the
University of Sussex Animal Welfare and Ethical Review Board.
RESULTS
d-Tubocurarine and Berbamine Protect
Zebrafish Lateral Line Hair Cells from
Aminoglycoside Damage
In order to assess the protective capabilities of dTC and
berbamine against aminoglycoside damage, a protection assay
was performed using hair cells in the lateral line organs of
zebrafish larvae at 4 dpf. This time point ensures the reliable
loading of Yo-Pro 1 (Santos et al., 2006; Kindt et al., 2012). dTC
was found to fully protect against damage induced by 6.25 µM
neomycin in zebrafish larvae at concentrations ≥12.5 µM, with
partial protection at 6.25µM(Figures 1A–F, 2A). Full protection
against damage induced by 10µMgentamicin was only observed
at concentrations ≥50 µM dTC, with partial protection at
25 µM (Figures 1G–L, 2B). Berbamine protected at somewhat
lower concentrations compared to dTC. It fully protected against
neomycin-induced neuromast damage in zebrafish larvae at
concentrations ≥12.5 µM, with partial protection even down to
1.55 µM, the lowest concentration tested (Figures 1M–R, 2C).
Berbamine offered full protection against gentamicin damage
at 25 µM and above, with partial protection at 12.5 µM
(Figures 1S–X, 2D). No signs of toxicity due to either compound
were observed at the highest concentration tested (200 µM).
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FIGURE 1 | d-Tubocurarine and berbamine protect lateral line hair cells in zebrafish from gentamicin and neomycin induced damage. Zebrafish were treated with:
(A,G,M,S) E3 alone (B) 6.25 µM neomycin, or (C–F) 25, 12.5, 6.25, or 3.1 µM of dTC plus 6.25 µM neomycin, (H) 10 µM gentamicin, (I–L) 25, 12.5, 6.25, or 3.1 µM
of dTC plus 10 µM gentamicin, (N) 6.25 µM neomycin, (O–R) 25, 12.5, 6.25, or 3.1 µM of berbamine plus 6.25 µM neomycin, (T) 10 µM gentamicin, (U–X) 25,
12.5, 6.25, or 3.1 µM of berbamine plus 10 µM gentamicin. Neuromasts were pre-stained with 3 µM Yo-Pro1. n > 3 independent experiments with at least 3 fish per
well. Images were obtained with a 40X objective. Scale bar = 25 µm.
d-Tubocurarine and Berbamine Protect
Mouse Cochlear Hair Cells from
Aminoglycoside Damage, but Berbamine Is
Toxic at Higher Concentrations
dTC and berbamine were subsequently tested in mouse cochlear
cultures to see if they would protect mammalian cochlear hair
cells from the damage induced by exposure to 5 µM gentamicin
for 48 h (Figures 3A–D). Such treatment results in the nearly
complete loss of OHCs from the basal 35% of the cochlea, but has
little effect if any on the survival of IHCs. dTC and berbamine
were found to be protective at minimum concentrations of 25
µM and 20 µM, respectively, as quantified in Figures 4A,B,
which show counts of OHCs in a 220 µm wide segment of
the basal coil of the cochlea. As a further criterion to assess
the suitability of a compound for use as an otoprotectant we
examined the hair-bundle morphology. No hair-bundle damage
was observed during exposure to either compound.
To determine if either compound had any adverse effects on
hair cells in the absence of gentamicin, they were tested alone
at a higher concentration of 50 µM. Berbamine was found to
be generally cytotoxic and killed both the IHCs and OHCs as
well as other cell types in the entire organ of Corti, whereas dTC
had no adverse effects on hair cells or hair-bundle morphology
at this concentration (Figures 3E, 4A). Berbamine was tested
alone at the lower concentrations of 20 and 30 µM and found
to be equally toxic at 30 µM as it was at 50 µM (no IHCs or
OHCs could be identified) but not at 20µM, the concentration at
which it showed protection against 5 uM gentamicin (Figures 3F,
4B). When 30 µM berbamine was tested together with 5 µM
gentamicin, the same cytotoxic effect was observed as with
30µM berbamine alone. While berbamine can thus protect from
gentamicin toxicity, albeit over a narrow concentration range, we
saw no evidence that gentamicin could protect from berbamine
cytotoxicity.
d-Tubocurarine and Berbamine Block MET
Channel Currents in Mouse Cochlear Hair
Cells
To determine whether the protection observed for both
compounds may be the result of a direct interaction with
the hair cells’ MET channels, thereby reducing or preventing
aminoglycoside entry, we examined the effect of dTC and
berbamine on the MET currents in basal-coil OHCs, the cells
that are predominantly affected by aminoglycoside ototoxicity.
Although dTC has previously been described as a MET channel
blocker (Glowatzki et al., 1997; Farris et al., 2004), no such
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FIGURE 2 | Cell count analysis for lateral line hair cell protection against gentamicin and neomycin by d-tubocurarine and berbamine. (A–D) A range of concentrations
(1.55–200 µM) of either dTC or berbamine with either neomycin or gentamicin are compared to neomycin or gentamicin alone. Number of hair cells were counted in
trunk neuromast 4. (A) dTC against neomycin, (B) dTC against gentamicin, (C) berbamine against neomycin and (D) berbamine against gentamicin. Cells counts that
are significantly different from aminoglycoside alone are indicated above the bars, with the number of stars representing the level of significance. The letter P in the
bars indicates concentrations that were deemed partially protective, because cell counts were also significantly different from the control (A: ***; B: ***; C: ***; D: **).
Numbers above the bars indicate experimental replicates, with cell numbers in three neuromasts counted and averaged for each replicate. *p < 0.05; **p < 0.01; ***p
< 0.001.
study has been carried out with berbamine. MET currents
were recorded at membrane potentials ranging from −164 to
+96 mV before, during and after superfusion with dTC or
berbamine at concentrations ranging from 300 nM to 100 µM
(dTC), or 1 to 30 µM (berbamine). During exposure to either
dTC or berbamine, a reduction in the current sizes was seen
when the cells were stepped to hyperpolarized potentials. This
reduction was less pronounced at depolarized potentials, with the
level of the reduction being dependent upon the concentration
of the compound. Examples of MET current block by dTC
and berbamine at a concentration of 3 µM are shown in
Figures 5A,B. Note that currents before and after application
of the compounds appear as rectified versions of the sinewave
stimulus. During superfusion of the compounds the currents look
similar at positive potentials, but at negative potentials the MET
currents can be seen to decline rapidly on each cycle after an
initial inward current peak. This is suggestive of an open-channel
blockingmechanism, where the blocker can only interact with the
open channel. The block of the channel and subsequent washout
were both rapid, with the currents making a full recovery upon
re-exposure to the control superfusion solution, indicating that
the block by both dTC and berbamine is completely reversible
(Figures 5A,B).
Average normalized current-voltage curves show the
extracellular block by dTC and berbamine at a range of
concentrations (Figures 6A,B). These curves clearly demonstrate
both the increase in the block with increasing compound
concentration and the voltage dependence of the block, with
minimal block at the depolarized potentials and stronger block
at the hyperpolarized potentials.
To examine whether either compound has an effect on the
MET currents when applied from the intracellular side of the
channel, dTC and berbamine were included in the intracellular
patch pipette solution at varying concentrations to enable their
entry into the cells. Transducer currents were recorded in the
same way as for the extracellular experiments, but omitting
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FIGURE 3 | d-Tubocurarine and berbamine protect cochlear OHCs from
gentamicin damage. Protection assay using cultures prepared from CD-1 mice
at postnatal day 2 (P2). Cultures were stained with TRITC-phalloidin at the end
of the experiment allowing visualization of the actin-rich stereocilia. (A) Control
culture incubated for 48 h in the presence of medium alone. The sensory hair
(Continued)
FIGURE 3 | Continued
cell loss shown in (B) caused by 48 h incubation with 5 µM gentamicin can be
prevented by co-incubation with 25 µM dTC (C) or 20 µM berbamine (D).
Cells incubated in 50 µM dTC in the absence of gentamicin were not
damaged (E), whereas 30 µM berbamine resulted in widespread loss of IHCs,
OHCs and other cell types (F). Scale bar = 50 µm.
any local superfusion of the cells. Intracellular berbamine at
concentrations of 100 and 300 µM was found to have no
effect on the size of the MET currents (data not shown). A
higher concentration of 1 mM resulted in the rapid loss of
the cells and the inability to maintain whole-cell recordings in
every cell tested. Conversely, intracellular dTC, at concentrations
ranging from 100 µM to 1 mM, was found to reduce the
current size when cells were depolarized but not when they
were hyperpolarized, indicating a block of the channel from
the intracellular side. Average normalized current-voltage curves
showing this intracellular block are shown (Figure 6C). Again,
these curves clearly demonstrate the voltage dependence of the
block and the increase in block with increasing compound
concentration.
Dose-response curves for the extracellular block of the MET
channels by dTC and berbamine were generated (Figures 7A,B).
These curves were derived from the currents measured at −104
mV, near the membrane potential at which the block was seen to
be the strongest, and fitted with the equation:
I
IC
=
1
1+
(
[B]
KD
)nH (2)
where IC is the control current in the absence of the compound,
[B] is the concentration of the blocking compound,KD is the half-
blocking concentration and nH is the Hill coefficient. From these
curves, the KD for dTC was found to be 2.2 µM (95% CI 1.7
µM to 2.7 µM), a value very similar to the previously reported
value for neonatal mouse OHC MET channel block of 2.3 µM
(Glowatzki et al., 1997). The KD for berbamine was found to be
2.8 µM (95% CI 2.4–3.2 µM), similar to the styryl dye FM1-43
(2.4 µM at −104 mV: Gale et al., 2001) and not significantly
different from dTC. Both dTC and berbamine have a higher
affinity for the MET channel than DHS, which has a reported KD
of 10 µM (Marcotti et al., 2005). The Hill coefficients calculated
from the dose-response curve fits were 1.02 for berbamine and
0.80 for dTC, the latter a value that is significantly smaller
than one (p < 0.05). These values suggest that, in the case
of berbamine, a single molecule interacts with and blocks the
channel whereas for dTC two molecules are involved, showing
negative cooperativity (Wyman and Gill, 1990).
A dose-response curve for the intracellular block of the MET
channels by dTC was generated, derived from the currents
measured at +96 mV and fitted with Equation (2) (not shown).
From this curve dTC was found to block the intracellular side
of the channel with a KD of 880 µM (95% CI 700–1,070 µM)
and a Hill coefficient of 0.92, values similar to those found for
the intracellular block of the MET channel by DHS (Marcotti
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FIGURE 4 | Quantification of survival of OHCs exposed to gentamicin and otoprotective compounds. (A,B) Bar charts showing average numbers of OHCs remaining
after 48 h in medium alone (control), in medium containing 5 µM gentamicin, in 5 µM gentamicin plus different concentrations of compounds, and in medium
containing the compound alone. Number of OHCs were counted in a 220 µm wide field. Significant protection occurs at dTC concentrations of 25 µM and above
(A) and for 20 µM berbamine (B). While 50 µM dTC alone does not cause OHC damage, OHCs are obliterated at ≥30 µM berbamine, with or without gentamicin.
Numbers above the bars indicate experimental replicates. ***p < 0.001.
FIGURE 5 | Extracellular d-tubocurarine and berbamine block the OHC MET channel. (A,B) MET currents recorded from P2+2 OHCs before, during and after
superfusion with a solution containing 3 µM dTC (A) or 3 µM berbamine (B). Both compounds can be seen to predominantly block the MET currents at
hyperpolarized potentials with the block fully reversible as seen from the washouts. Membrane potentials were stepped between −164 mV and +96 mV and MET
currents were recorded in response to a sinewave delivered by a fluid jet (45 Hz sinusoid, ±40 V driver voltage, DV) shown above each trace. The capacitances of the
cells were 6.9 pF (A) and 7.8 pF (B).
et al., 2005; Corns et al., 2016). These values show that the affinity
of dTC for the MET channel is greatly reduced when blocking
from the intracellular side as opposed to the extracellular
side.
Fractional block curves for both dTC and berbamine at all
concentrations tested were plotted (Figures 8A,B). The data were
fitted with a two-barrier, one binding-site (2B1BS) model similar
to that previously used to describe the block of the MET currents
by DHS (Marcotti et al., 2005) but adapted to allow for Hill
coefficients different from one (van Netten and Kros, 2007;
see Section Materials and Methods). For plotting the fractional
block, the half-blocking concentration KD in Equation (2) above
becomes voltage-dependent as follows:
KD =
[
K1(V)
] 1
nH with
K1(V) = exp
(
Eb
kT
+
δbV
Vs
)
·
(
1+ exp
(
−
1E
kT
−
V
Vs
))
, (3)
where 1E = E2 − E1, the slope factor: Vs = kTze0 , is the
ratio of thermal energy (kT, i.e., Boltzmann’s constant multiplied
by absolute temperature) and effective charge of the blocker
molecule (ze0, i.e., valence multiplied by elementary charge) and
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FIGURE 6 | Normalized current-voltage curves reveal the voltage-dependence
of d-tubocurarine and berbamine MET channel block. (A,B) Average
normalized current-voltage curves for the peak MET currents recorded before
and during extracellular superfusion with 300 nM to 100 µM dTC (A), or 1 to
30 µM extracellular berbamine (B). Currents were normalized to the peak
current measured at +96 mV. For the two compounds, block increases with
both increasing hyperpolarization and compound concentration. Inclusion of
0.1 to 1 mM dTC in the patch-pipette resulted in a block of the MET currents
from the intracellular side at depolarized potentials (C). Currents in (C) were
normalized to the peak current measured at −164 mV. Numbers of cells and
peak current (A) Control: 43, 0.92 ± 0.05 nA; 300 nM: 5, 1.01 ± 0.14 nA; 1
µM: 6, 1.00 ± 0.09 nA; 3 µM: 9, 0.89 ± 0.10 nA; 10 µM: 5, 0.75 ± 0.09 nA;
30 µM: 13, 0.78 ± 0.10 nA; 100 µM: 5, 0.32 ± 0.03 nA (B) Control: 37, 0.65
± 0.07 nA; 1 µM: 6, 0.76 ± 0.19 nA; 3 µM: 14, 0.51 ± 0.10 nA; 10 µM: 8,
0.54 ± 0.11 nA; 30 µM: 9, 0.38 ± 0.11 nA (C) Control: 10, −1.86 ± 0.13 nA;
100 µM: 3, −1.84 ± 0.31 nA; 300 µM: 2, −1.95 ± 0.12 nA; 1 mM: 5, −1.40
± 0.13 nA.
FIGURE 7 | d-Tubocurarine and berbamine block MET channels with similar
half-blocking concentrations. (A,B) Dose-response curves of MET channel
block by dTC (A) and berbamine (B) derived from currents recorded at −104
mV and fit with Equation (2). dTC: KD 2.2 µM, Hill coefficient 0.80; berbamine:
KD 2.8 µM, Hill coefficient 1.02. From 5 to 14 cells were used for each data
set.
δb is the relative electrical distance of the binding site along the
membrane.
The data and fitted curves show that block is voltage-
dependent for both compounds, with block being released
strongly at positive potentials but also, to a lesser extent, at
extreme negative potentials—the latter indicative of permeant
block in which the compounds enter the cell with a sufficiently
strong electrical driving force. This release at hyperpolarized
potentials was more pronounced for berbamine than for dTC.
The membrane potential of maximum block was −118 mV for
dTC and−94 mV for berbamine.
Large step stimuli were applied to the cells before and during
superfusion of the compounds to confirm whether or not the
channel is required to open before block can occur, i.e., whether
the compounds act as open-channel blockers, as suggested by
the MET currents recorded in response to sinusoidal stimuli
(Figures 5A,B), and to quantify the time course of the block.
Currents were recorded in response to a large force step
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FIGURE 8 | Fractional block of the MET currents by d-tubocurarine and
berbamine shows that both are permeant blockers. (A,B) Fraction of the MET
current remaining during dTC (A) or berbamine (B) superfusion relative to the
control current at the same membrane potential. Concentrations ranged from
300 nM to 100 µM (dTC) or 1 to 30 µM (berbamine). Data are fitted with a
two-barrier, one binding-site model (see Section Materials and Methods). A
release of the block at extreme hyperpolarized potentials indicates that both
compounds can enter the cells. Maximum current block is seen at −118 mV
(dTC) and −94 mV (berbamine). Fitted parameters were for dTC 1E 4.96 kT;
Eb −8.67 kT; z 1.09; δb 0.52, and for berbamine 1E 2.68 kT; Eb −12.0 kT; z
0.94; δb 0.57. Number of cells (A) 300 nM: 5, 1 µM: 6, 3 µM: 9, 10 µM: 5, 30
µM: 13, 100 µM: 5 (B) 1 µM: 6, 3 µM: 14, 10 µM: 8, 30 µM: 9.
before and during superfusion with different concentrations of
each compound (3–30 µM; examples of recordings are shown
in Figures 9A–D). In the absence of the blockers the force
steps result in large, saturating MET currents showing minimal
adaptation. Upon superfusion of either dTC or berbamine the
currents activate with the same rapid time course, followed
by an exponential decline in the currents, with the speed
of the decline increasing with increasing concentration. This
decline in the current following channel opening indicates that
both compounds act as open-channel blockers and can only
access their binding site once the channel is open. The time
constants measured from the MET current decline allow for
a calculation of the rate constants for entry into the channel
from the extracellular side (k1; see Marcotti et al., 2005; van
FIGURE 9 | Kinetics of MET channel block reveal d-tubocurarine and
berbamine act as open channel blockers. (A–D) Transducer currents were
recorded from OHCs in response to a mechanical step delivered by a fluid-jet
(±40 V driver voltage, DV), shown above each trace [(A,B) P2+2; (C,D)
P2+3]. From a holding potential of −84 mV, cells were exposed to an initial
saturating inhibitory stimulus, resulting in the closure of the MET channels,
followed by a saturating excitatory step eliciting rapidly activating inward
currents. Currents (averaged from 10 repetitions) before (black trace) and
during (red trace) superfusion of 3 µM dTC (A), 30 µM dTC (B), 3 µM
berbamine (C), and 30 µM berbamine (D) were scaled and superimposed.
Maximum transducer currents were; (A) −679 pA before and −369 pA during
3 µM dTC application, (B) −742 pA before and −137 pA during 30 µM dTC
application, (C) −271 pA before and −211 pA during 3 µM berbamine
application and (D) −271 pA before and −67 pA during 30 µM berbamine
application. Both dTC and berbamine can be seen to act as open channel
blockers from the decline in current size observed following the excitatory step.
The currents during compound superfusion were fitted with single exponentials
(A) τ = 6.9 ms (B) τ = 2.1 ms (C) τ = 3.2 ms (D) τ = 0.83 ms. (E) Entry rates
into the OHC of extracellular dTC and berbamine as a function of membrane
potential. At all membrane potentials berbamine enters the cell more rapidly
than dTC. Rates calculated for 1 µM compound, 80 channels, popen 0.1.
Netten and Kros, 2007). Mean values of the time constants
were, for dTC, 6.7 ± 0.6 ms (n = 7 OHCs) for 3 µM and
2.1 ± 0.2 ms (n = 6) for 30 µM. For berbamine at 3 µM
the time constant was 4.7 ± 0.4 ms (n = 10), at 10 µM 2.45
± 0.15 (n = 5) and at 30 µM 0.97 ± 0.22 ms (n = 3).
From these values, the entry rates into the hair cells can be
calculated. At all potentials berbamine enters more avidly than
dTC (Figure 9E).
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 September 2017 | Volume 11 | Article 262
Kirkwood et al. Otoprotective Permeant MET-Channel Blockers
Effect of the Compounds on the
Basolateral Potassium Currents in Mouse
Outer Hair Cells
dTC is a known nicotinic antagonist that has also been shown to
block various potassium channels including the apamin-sensitive
potassium current in neurones (Goh and Pennefather, 1987),
cloned small conductance calcium-activated potassium (SK)
channels (Ishii et al., 1997) and a calcium-dependent potassium
current in rat tumoral pituitary cells (Vacher et al., 1998). During
the first postnatal week OHCs express a slow outward K+ current
(IK,neo) activated at potentials positive to −50 mV (Marcotti
and Kros, 1999). We therefore investigated whether dTC or
berbamine could suppress this current and confer additional
protection through causing a shift in restingmembrane potential,
with any depolarization of the cell potentially resulting in a
reduced driving force for the positively charged aminoglycosides
to enter the cells. Currents were elicited by applying a series of
hyperpolarising and depolarizing voltage steps from the holding
potential of −84 mV and currents recorded before and during
exposure to 30 µM of each compound. Berbamine was found
to substantially reduce IK,neo whereas dTC had no effect at this
concentration (Figure 10A). Average normalized current-voltage
curves for all cells recorded from are shown (Figure 10B).
Notably, neither compound elicited a reduction in the resting
membrane potential when it was perfused onto OHCs under
current clamp at a concentration of 30 µM (Figure 10C).
In fact the reverse was observed, with similar increases in
resting membrane potential during both dTC and berbamine
superfusion. This hyperpolarization, which would lead to an
increase in the electrical force driving the aminoglycosides to
enter the hair cells, eliminates changes in resting membrane
potential as a potential protective mechanism for both dTC and
berbamine.
d-Tubocurarine and Berbamine Reduce
GTTR Loading into Cochlear Hair Cells
In order to test whether either compound could block or reduce
the accumulation of gentamicin into the OHCs, mouse cochlear
cultures were exposed to a low concentration (0.2 µM) of GTTR
in the presence of a large molar excess (100 µM) of each
compound for a short period of time to enable a quantification
of the gentamicin uptake (Steyger et al., 2003). For a negative
control, cultures were incubated in 0.2µMGTTR and 1%DMSO
alone. Following a 5 min pre-incubation with dTC, berbamine
or DMSO alone and a subsequent 10 min co-incubation with
0.2 µM GTTR, a significant decrease in GTTR loading was seen
in OHCs that were exposed to GTTR in the presence of either
dTC or berbamine compared to the DMSO vehicle controls
(Figures 11A–D). The reduction in GTTR labeling observed with
the two compounds was similar and not significantly different.
DISCUSSION
The results of this study show that berbamine protects hair cells
in mouse cochlear cultures from gentamicin toxicity, and that
dTC can protect zebrafish lateral line hair cells from the toxic
FIGURE 10 | Basolateral potassium currents are blocked by berbamine but
not by d-tubocurarine. (A) Currents from an OHC recorded before and during
exposure to 30 µM dTC or berbamine reveal a decrease in current size during
berbamine, but not dTC superfusion. Currents were recorded in response to
10 mV hyperpolarizing and depolarizing voltage steps from a holding potential
of −84 mV. Schematic representations of the voltage step protocols are
shown below each trace. The leakage currents have been subtracted but the
membrane potentials have not been adjusted for the residual series resistance
(3.0 M). The capacitance of the cell was 6.7 pF. (B) Average normalized
steady-state I-V curves for all cells before (closed symbols; n = 12) and during
exposure to 30 µM dTC (open circles; n = 9) or 30 µM berbamine (open
triangles; n = 8). (C) Monitoring membrane potential changes under current
clamp revealed that exposure to both 30 µM berbamine and 30 µM dTC
resulted in a hyperpolarization of the cell of more than 10 mV from the resting
potential of −55 mV.
side effects of both neomycin and gentamicin. Furthermore, we
confirm previous observations showing that dTC can protect
mammalian hair cells from gentamicin (Alharazneh et al.,
2011) and that berbamine can protect zebrafish hair cells from
aminoglycoside toxicity (Kruger et al., 2016). The two alkaloids
dTC and berbamine are therefore versatile otoprotectants that
work in both fish and mammals.
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FIGURE 11 | d-Tubocurarine and berbamine reduce the loading of GTTR. (A) dTC and berbamine significantly reduced the fluorescent intensity of 0.2 µM GTTR
compared to DMSO controls (***p < 0.001). No significant difference was seen between the reduction by dTC and berbamine. Fluorescent intensity was measured in
arbitrary units (a.u.). Error bars are ±SEM. (B–D) Representative images taken following 10min GTTR exposure in DMSO, dTC and berbamine. Scale bar = 50 µm.
Following on from this we set out to determine whether
berbamine and dTC share the same mechanism of protection
in mammals. The MET channels are the main entry site for the
aminoglycosides into the hair cells (Marcotti et al., 2005) and a
block of these channels has been suggested as the mechanism of
protection for both berbamine in zebrafish lateral line hair cells
(Kruger et al., 2016) and curare in rat OHCs (Alharazneh et al.,
2011). Furthermore, previous studies have shown also that dTC
is a MET channel blocker (Glowatzki et al., 1997; Farris et al.,
2004). Our results clearly demonstrate that both compounds act
as permeant blockers of the MET channel, rapidly and reversibly
blocking the channels with similar half-blocking concentrations.
Maximum block is seen at −118 mV for dTC and −94 mV
for berbamine, with the block reducing at more hyperpolarized
potentials, indicating both compounds can enter into the cells,
albeit at a greatly reduced rate compared to the aminoglycoside
DHS (Marcotti et al., 2005). For example, with the conditions
chosen for Figure 9E (1 µM compound, 80 MET channels, popen
0.1), the entry rates into the OHCs are 110 molecules/s for dTC
and 205 molecules/s for berbamine, at a membrane potential
of −150 mV. Taking the parameters for DHS permeation in
the presence of 1.3 mM extracellular Ca2+ from Marcotti et al.
(2005), the entry rate of 1 µM DHS into the cells would be
some 1,130 molecules/s, an order of magnitude faster. For higher
concentrations the entry rates started to saturate, so rates for dTC
and berbamine can never approach those for DHS (e.g., for 100
µM rates were 319 molecules/s for dTC, 1107 molecules/s for
berbamine and 11,460 molecules/s for DHS).
Whilst a previous study has reported that dTC is non-
permeant and remains in the channel pore (Farris et al., 2004),
this finding was based on studies in turtle auditory hair cells
in which the cells were not hyperpolarized much beyond the
potential at which we observe maximum block. The release of
the block was therefore not observed. In our study cells were
hyperpolarized to –164 mV, a potential at which a release of
the block was clearly evident. This is a physiologically relevant
membrane potential as the electrical driving force across the
MET channels in the mammalian cochlea in vivo is generated by
a positive endocochlear potential of +80 to +100 mV (Bosher
and Warren, 1971) and a negative hair-cell resting potential of
some −40 to −60 mV (Johnson et al., 2011). In turtle hair
cells, Farris et al. reported KD values for dTC block of 6.3 µM
for the steady-state current and 16 µM for the peak current,
values ∼3–8 times higher than our (near steady-state) finding of
2.2 µM. They also calculated a Hill coefficient of 2 suggesting
the cooperative binding of 2 dTC molecules in the channel
pore as opposed to the negative cooperativity suggested by our
finding of a Hill coefficient of 0.8. These observations imply
marked differences between the turtle and mouse MET channels,
highlighting the need for caution in interpreting results across
species.
Both dTC and berbamine significantly reduce the loading
of GTTR into the OHCs. This observation, together with the
knowledge that they are both MET channel blockers with a
reasonably high affinity for the channel pore, strongly suggests
that protection is conferred via a competitive block of the
channels. Both compounds can, however, enter the cells so it is
possible that there are alternative and/or additional intracellular
targets. This seems unlikely though as dTC and berbamine
provide protection against both neomycin and gentamicin in
zebrafish, a species in which these aminoglycosides activate
distinct cell death pathways (Owens et al., 2009; Coffin et al.,
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2013a,b) and may have different targets (Owens et al., 2008;
Vlastis et al., 2012). Although berbamine and dTC are both
permeant, open-channel blockers of the hair cell’s MET channel
that reduce GTTR loading into hair cells and protect against
aminoglycoside toxicity, berbamine was found to be toxic to
mammalian hair cells and other cell types in the developing organ
of Corti at concentrations ≥30 µM. It also blocks the hair cell’s
basolateral K+ current IK,neo. As mentioned above, berbamine is
more permeant than dTC, and the energy profiles (Figure 12)
indicate substantial differences between their interactions with
theMET channel, with dTC having higher entry and exit barriers.
The latter feature would hinder its entry into the hair cells.
FIGURE 12 | Energy profiles for MET channel permeation and block by
extracellular d-tubocurarine and berbamine. Energy profiles calculated from fits
to the fractional-block curves and kinetics of MET current block are shown.
Values for the free energies of the binding site Eb and barriers E1 and E2 are
shown in the absence of a voltage across the membrane (Vm = 0 mV). The
voltage-independent extracellular barrier E1, at an electrical distance of zero,
has a free energy of 15.16 kT for dTC and 12.14 kT for berbamine. Eb is
−8.67 kT for dTC and −12.0 kT for berbamine. The binding sites, δb, are
located at an electrical distance from the extracellular side of 0.52 for dTC and
0.57 for berbamine. The intracellular barrier E2, positioned at an electrical
distance of one, is 20.13 kT for dTC and 14.82 kT for berbamine.
dTC is an alkaloid formed of two isoquinoline moieties linked
via hydroxyl-benzyl groups to form an 18 atom macrocycle.
It bears one fixed positive charge (quaternary nitrogen) and
a pH dependent positive charge (tertiary nitrogen, calculated
pKa ∼8.0). Ionization simulation shows that at physiological pH
∼80% of themolecule will bear two positive charges. The distance
between the two positive charges of dTC (Figure 13A), with
the stereochemistry of the carbon atoms next to the quaternary
and the tertiary nitrogens being R and S respectively, is 8.89
Å. Whilst berbamine is an 18 atom macrocycle alkaloid that is
structurally related to dTC and bears the same two isoquinoline
moieties the latter are, however, linked differently. In comparison
to dTC, berbamine does not bear any fixed positive charge but
has instead two pH dependent ones, with the calculated pKa
for the two tertiary nitrogens being ∼7.4 and 8.2. Prediction of
ionization status at physiological pH suggests that 50% of the
molecules will bear two positive charges and ∼40% only one
positive charge. The distance between the two positive charges
for berbamine, with the stereochemistry of the carbon atoms next
to the two nitrogens being R and S (Figure 13B), is 10.18 Å,
slightly higher than that in dTC. Flexible alignment of the two
structures (Figure 13C) shows a good overall superimposition
of the molecules; however, the isoquinoline moiety bearing
the quaternary nitrogen of dTC and one of the two tertiary
nitrogens of berbamine do not superimpose properly with the
two nitrogens being 1.2 Å apart from each other.
Some of the differences between the structures of dTC and
berbamine outlined above may explain why their properties and
interactions with theMET channel are different. For example, the
higher entry and exit energy barriers for dTC could tentatively
be explained by the fact that a higher percentage of dTC
molecules will bear two positive charges compared to berbamine
molecules at physiological pH, thereby hindering the passage of
dTC across the positive charges present at the mouth and exit
of the channel (van Netten and Kros, 2007). Alternatively, the
distance between the positive charges may critically determine
the strength of interactions with the MET channel protein. As
discussed earlier, dTC and berbamine are both less permeant than
the aminoglycoside DHS (Marcotti et al., 2005), entering the cells
at a substantially slower rate, by an order of magnitude. This may,
in part, be explained by the fact that dTC and berbamine both
FIGURE 13 | d-Tubocurarine and berbamine share similar chemical structures. (A,B) Energy-minimized structures showing the distance between the positive charges
for dTC (8.89 Å; yellow) and berbamine (10.18 Å; magenta) respectively. (C) A flexible alignment with the structures not minimized reveals dTC and berbamine share
striking structural similarities.
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have a more rigid structure, are less flexible compared to DHS,
and may therefore be unable to adapt their conformation within
the channel.
In the search for potential otoprotective compounds we
have identified dTC as a promising lead compound for further
investigation. dTC is a reasonably high-affinity MET channel
blocker (KD = 2.2 µM) that rapidly and reversibly blocks the
channel. It has advantages over berbamine which include reduced
permeability and a lack of toxicity up to 50 µM. By comparison
berbamine had only a narrow range of protective concentrations
in the cochlea, as it was found to be toxic at concentrations above
30 µM. Moreover, berbamine damaged OHCs when applied
intracellularly at 1mM. As berbamine was not toxic to neuromast
hair cells, and protected these cells at lower concentrations than
dTC, results from the zebrafish assay alone would have favored
berbamine over dTC as a potential otoprotective compound.
This points to the necessity to follow-up results from zebrafish
screening with a mammalian otoprotection assay. One future
approach would be to modify dTC in order to increase its
affinity for the MET channel and eliminate its ability to enter
the cells. In parallel one would need to reduce its action as a
nicotinic antagonist to avoid blocking the middle ear reflex and
the action of the olivocochlear bundle following trans-tympanic
application.
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